The U.S. Dept. of Health and Human Services (HHS) and Defense Dept. (DoD) announced a COVID-19 vaccine distribution deal with McKesson. Under Operation Warp Speed, McKesson will become a central distributor of future COVID-19 vaccines and related supplies needed to administer the pandemic vaccinations, according to a news release. The Centers for Disease Control and…
Pfizer to make Gilead’s remdesivir COVID-19 treatment
Pfizer (NYSE:PFE) announced today that it entered into a multi-year agreement with Gilead Sciences (NSDQ:GILD) to manufacture and supply its antiviral remdesivir treatment. The investigational antiviral remdesivir will be manufactured by Pfizer under the agreement as the company becomes one of the multiple external manufacturing organizations supporting efforts to scale up the supply of the investigational…
U.S. to spend $1B for doses of J&J’s COVID-19 vaccine candidate
The U.S. Dept. of Health and Human Services and Defense Dept. agreed to a $1 billion deal for a vaccine candidate from Johnson & Johnson (NYSE:JNJ). HHS and DoD announced the agreement with Janssen Pharmaceutical, as the J&J subsidiary is set to offer large-scale manufacturing and the delivery of its COVID-19 vaccine candidate, with the federal…
Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK
Sanofi (NYSE:SNY) and GlaxoSmithKline (NYSE:GSK) announced that they reached an agreement with the UK government to supply up to 60 million doses of a COVID-19 vaccine. Subject to a final contract, the UK government will receive the doses of a vaccine candidate developed by the two companies in partnership and based on the recombinant protein-based technology Sanofi used to…
SP Industries announces partnership with Ecodyst
Fill-finish drug manufacturing solutions developer SP Industries announced that it entered into a partnership agreement with evaporator developer Ecodyst. Apex, N.C.-based Ecodyst offers a full range of single-sample evaporators with self-cooling condenser technology. The distribution partnership aims to utilize the Ecodyst products to complement Warminster, Pa.-based SP Industries’ SP Genevac with parallel centrifugal evaporators to…
Teknova announces new CEO
Cell culture media, protein purification and molecular biology reagent manufacturer Teknova announced that it appointed Stephen Gunstream as its new CEO. Gunstream has nearly 20 years of experience in life sciences, having previously served as VP and GM for the research and clinical business at BD Biosciences, as well as the CCO at Integrated DNA…
WMFTG announces the launch of its new Certa Plus pump series
Watson-Marlow Fluid Technology Group (WMFTG) announced that it launched its Certa Plus pump series for versatile fluid management in pharmaceuticals. Certa Plus uses the company’s MasoSine sinusoidal pumping technology to function across a range of applications with lower shear, lower power consumption, full traceability and cleanability when transferring syrups, oils, creams and gels, according to…
Tekni-Plex introduces new Pentafill L + Fill bench-top vial filling/sealing machine
Tekni-Plex announced that it is debuting a new bench-top vial filling and sealing machine designed for lab research and small quantity start-up production. The Pentafill L + Fill machine is an upgrade to Tekni-Plex’s previous Pentafill L unit, which only seals vials. The latest tech accommodates five-unit strips of 0.33-, 0.6-, 1-, 3-, 5- and…
Inovio to scale up production of smart delivery device for potential COVID-19 vaccine
Inovio Pharmaceuticals (NSDQ:INO) announced that it received $71 million from the U.S. Defense Dept. to support its Cellectra 3PSP smart device. Funding from the DoD is set to support large-scale manufacturing for the Cellectra 3PSP and the procurement of Cellectra 2000 devices, which are used to deliver its INO-4800 COVID-19 vaccine candidate directly into the skin.…
HHS taps Pfizer to produce millions of COVID-19 vaccine doses
Two U.S. government agencies today announced an agreement with Pfizer (NYSE:PFE) for production and delivery of 100 million doses of a COVID-19 vaccine. The U.S. Dept. of Health and Human Services, along with the U.S. Defense Dept., agreed to the large-scale production and U.S. delivery deal once Pfizer’s vaccine is successfully manufactured and approved. In addition to…